Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad, Luminex to Commercialize Protein System

NEW YORK, Dec 12 - Bio-Rad Laboratories and Luminex said Tuesday they had entered into an agreement to jointly commercialize a system for drug discovery applications based on Luminex's LabMAP technology.

Bio-Rad has incorporated Luminex's microsphere-based assay technology and reader into its Bio-Plex Protein Array System. The new product, which will be available in the first quarter of 2001, is the outcome of a two-year collaboration between the companies.

Financial terms of the deal and the collaborative marketing arrangement were not disclosed.

The system, which combines a Luminex analyzer, Bio-Rad’s software, and reagent kits, is designed to help researchers in the life sciences market to easily extract more data from small samples.

Luminex's system is designed to perform up to 100 assays simultaneously on a single drop of fluid, with the capability for both medium- and high-throughput assay applications.

" The hallmark of Bio-Rad Laboratories' integrated Bio-Plex system is that it comes equipped with distinctive improvements in application software and optimized assay kit formulation," Norman Schwartz, vice president of Bio-Rad's life science group, said in a statement.

" These features significantly increase the utility and ease-of-use for researchers and broaden the appeal of the extremely powerful Luminex platform," he said.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.